pSivida Corp. (NASDAQ:PSDV) investors are excited today after the drug maker announced it has entered a collaboration agreement with Nicox S.
In a research report sent to investors today, MLV analyst Arlinda Lee reiterated a Buy rating on pSivida Corp (NASDAQ:PSDV) with a $6.50 …
In a research report issued today, MLV analyst Arlinda Lee reiterated a Buy rating on pSivida Corp (NASDAQ:PSDV) with a $6.50 price target, …